ARTICLE | Company News
Micromet, Bayer deal
December 7, 2009 8:00 AM UTC
Bayer's Bayer Schering Pharma AG subsidiary exercised its option to license exclusive, worldwide rights to co-develop and commercialize a Bispecific T cell engager (BiTE) antibody from Micromet agains...